AI assistant
Medicamen Biotech Ltd. — Major Shareholding Notification 2021
Dec 29, 2021
61898_rns_2021-12-29_cf5a0ce4-0d3d-420b-a654-ee82a6818040.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
EDICAMEN Biotech Limited

Regd. & Corp. Office: 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi - 110019 (INDIA)
Tel.: 011 - 47589500-51 (50 Lines), E-mail: [email protected] Web: www.medicamen.com CIN No.: L74899DL1993PLC056594
Dated: 29.12.2021
To. BSE Limited Floor 25, P J Towers Dalal Street Mumbai-400001
National Stock Exchange of India Ltd Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E) Mumbai - 400 051
Scrip Code: 531146
Subject: Intimation as per Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015
Dear Sir/Madam.
Please find attached disclosure dated December 29, 2021 in Form-C pursuant to Regulation $7(2)(a)$ read with Regulation $6(2)$ of the SEBI (Prohibition of Insider Trading) Regulations, 2015 with respect to intimation received from Growel Remedies Limited for sale of 46,010 Equity Shares from the open market.
We request you to treat this intimation as compliance with Regulation $7(2)$ (b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and take the same on record.
For Medicamen Biotech Limited 'ò E
Parul Choudhary Company Secretary ACS: 44157
Encl: A/a

Dated: 29.12.2021
To, The Compliance Officer Medicamen Biotech Limited 1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, 110019
Subject: Submission of disclosure under Regulation $7(2)(a)$ read with regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
Dear Sir/Madam,
With reference to the above captioned subject, we would like to apprise you that Growel Remedies Limited (Promoter of Medicamen Biotech Limited ("Target Company") has sold 46,010 Equity Shares of Rs. 10/- each through the open market.
In this connection please find enclosed the required disclosure.
You are requested to take the above information on your records and inform the exchange accordingly.
For Growel Remedies Limited Ashwani Kumar Sharma Director DIN: 00325634
Encl: A/a
Name of the company: Medicamen Biotech Limited ISIN of the company: INE646B01010
[Regulation 7 (2) read with Regulation $6(2) -$ Continual disclosure] SEBI (Prohibition of Insider Trading) Regulations, 2015 FORM C
$\overline{\phantom{a}}$
$\ddot{\phantom{0}}$
$\overline{1}$
Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate relatives of such persons and other
such persons as mentioned in Regul
| market/public acquisition / disposal (on preferential Mode of rights/ |
market/ Inter- offer / off transfer. ESOP S etc.) Se |
E pay On Market Ò |
OMO |
|---|---|---|---|
| intimation company Date of $\overline{c}$ |
29.12.2021 | ||
| disposal of shares Date of allotment acquisition of advice/ specify shares/ |
Гo | 28.12.2021 | |
| From | 27.12.2021 | ||
| aequisition/disposal Securities held post |
shareholding No. and % $\sigma$ |
equity shares $(2.08\%)$ 2.53.990 |
|
| Debenture s Rights Convertib (For eg- Warrants. entitleme Type of security Shares, nt. etc.) $\overline{e}$ |
Equity Shares |
||
| Securities aequired/Disposed | (Purchase Invocatio Transact Revocati specify) Others Pledge please Type /sale $\overline{\text{ion}}$ $\ddagger$ $\pm$ |
Sale | |
| Value (In Rs.) | Forty Four thousand Rupees Four Crore Seventy One Paise Rs. 4.54,44,459.71 Four Hundred and Four Lakhs Fifty Nine and $only(-)$ |
Note: "Securities" shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015 | |
| $\circ$ Z. |
46.010 Equity Shares |
||
| (For eg. Converti Warrant Debentu etc.)etc.) Type of security Rights entitlem Shares. ents res ble $\ddot{s}$ |
Equity Shares |
||
| aequisition/disposal Securities held prior to |
sharehold and $\frac{0}{6}$ Σò. $\overline{\Xi}$ $\overline{\mathrm{of}}$ |
3.00.000 equity shares $(2.46\%)$ |
|
| entitlements Convertible Debentures Warrants. - Shares, Type of security (For eg. Rights etc.) |
Equity shares | ||
| of Category of s/immediate group/desig (Promoter/ promoter member to/others Director relative person/ Person nated etc.) the |
Promoter (dno.fa) |
||
| & address CIN/DIN contact Name. PAN. with nos. |
Growel Wellness Innovations Ltd.) $\frac{\text{Constant}}{+919810739079}$ Tower.43. Nehru Address: 1506. Name: Growel AABCG3108P Place. New Delhi-110019 Remedies (formerly Chiranjiv Contact Limited PAN: |
Exchange on which the trade was Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2). executed Number of units Sell Notional Value Trading in derivatives (Specify type of contract, Futures or Options etc) Number of units (contracts * lot $\overline{Bu}y$ Notional Value specifications Contract Type of contract
$\overline{a}$
Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options.
X
$\frac{1}{2}$
$\frac{1}{2}$
$\frac{1}{2}$
$\frac{1}{2}$
NA
size) X
(contracts * lot size)
Yours faithfully
For Growel Remedies Ltd
median
ISWC Ashwani Kumar Sharma
Limi
DIN: 00325634 Director
Place: New Delhi Date: 29.12.2021
*******